The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD.

Authors:
Address: Department of Respiratory Medicine, University Hospital Llandough, Penarth, CF64 2XX, Wales. ramsey.sabit@gmail.com
Journal:

Publication:

abstract

BACKGROUND:

It has been demonstrated that There is an increased risk of venous thromboembolism (VTE) during air travel on flights of long duration. patients with COPD are also at increased risk of VTE, particularly during exacerbations, possibly because of a hypercoagulable state secondary to hypoxia and/or heightened systemic inflammation. We investigated the effects of hypoxia on indices of coagulation and systemic inflammation in patients with COPD.

METHODS:

Twenty clinically stable patients with mild COPD were recruited. Patients were randomized to receive either medical air or 100% nitrogen through a 40% venturi mask at a flow rate of 10 L/min for 2 h. Blood was sampled for thrombin-antithrombin complex (TAT), prothrombin activation fragments 1 + 2 (F(1 + 2)), von Willebrand factor antigen (VWF:Ag), D-dimer, and interleukin-6 (IL-6) at baseline and after 2 h.

RESULTS:

Patients in the hypoxia and control groups were similar in terms of age, sex, pack-years smoked, and severity of airflow obstruction. There was no difference in baseline TAT, F(1 + 2), VWF:Ag, D-dimer, or IL-6 levels between groups. In the control group, there was no change in markers of coagulation or systemic inflammation over the 2-h study. In patients who underwent hypoxic challenge, there was an increase in TAT (P < .001), F(1 + 2) (P < .01), and IL-6 (P < .01), whereas D-dimer and VWF:Ag levels were unchanged.

CONCLUSIONS:

This study demonstrates that a 2-h hypoxic challenge in patients with COPD results in coagulation activation in conjunction with an increase in systemic inflammation.

Related Articles
Systemic inflammation in patients with COPD and pulmonary hypertension.
Chest. 2006
Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P, Petrasova D, Stancak B, Tkacova R. Chest. 2006 Aug; 130(2):326-33.
[The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
Pneumonol Alergol Pol. 2010
[The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
Komnata K. Pneumonol Alergol Pol. 2010; 78(4):271-8.
Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
Lung. 2008
Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H. Lung. 2008 Nov-Dec; 186(6):403-9. Epub 2008 Sep 20.
Review [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Rinsho Byori. 2004
Review [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S. Rinsho Byori. 2004 Apr; 52(4):355-61.
Review The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease.
Proc Am Thorac Soc. 2005
Review The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease.
Tapson VF. Proc Am Thorac Soc. 2005; 2(1):71-7.
The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats.
PLoS One. 2010
The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats.
Feng J, Wang QS, Chiang A, Chen BY. PLoS One. 2010 Oct 6; 5(10):e13201. Epub 2010 Oct 6.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.